Javier Bolaños‐Meade

12.3k citations

119 papers · 4.2k indexed · h-index 32

Impact in

Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Transplantation top 1%
- Renal Transplantation Outcomes and Treatments

Papers in

Transplantation 26
- Renal Transplantation Outcomes and Treatments 26
Hematology 98
- Hematopoietic Stem Cell Transplantation 84
- Acute Myeloid Leukemia Research 12

Co-authors: Richard J. Jones Ephraim J. Fuchs Robert A. Brodsky Leo Luznik Richard F. Ambinder Vincent T. Ho John E. Levine Daniel J. Weisdorf
Journals: Biology of Blood and Marrow Transplantation (32 papers)Blood (31 papers)Blood Advances (5 papers)Journal of Clinical Oncology (5 papers)Transplantation and Cellular Therapy (5 papers)
Partner nations: United States Mexico France

In The Last Decade

Javier Bolaños‐Meade

113 papers receiving 4.1k citations

Peers

Countries citing papers authored by Javier Bolaños‐Meade

Since Specialization

Citations

This map shows the geographic impact of Javier Bolaños‐Meade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Bolaños‐Meade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Bolaños‐Meade more than expected).

Fields of papers citing papers by Javier Bolaños‐Meade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Bolaños‐Meade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Bolaños‐Meade. The network helps show where Javier Bolaños‐Meade may publish in the future.

Co-authors

The 25 scholars most cited alongside Javier Bolaños‐Meade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Javier Bolaños‐Meade Line = papers co-authored together Javier Bolaños‐Meade links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide Blood Advances ·Dipenkumar Modi, Yosra Aljawai, Todd E. DeFor, Caitrin Bupp, Monzr M. Al Malki, Javier Bolaños‐Meade, Mahasweta Gooptu, Antonio Jiménez, Hongtao Liu, Felix Mensah, Marco Mielcarek, Brian C. Shaffer, Bronwen E. Shaw, Stephen R. Spellman, Heather E. Stefanski, Jeffery J. Auletta, Steven M. Devine, Farhad Khimani, Ramzi Abboud	2025	1
2	DNMT3A, NPM1, and FLT3-ITD triple-mutated AML has a favorable prognosis in the era of FLT3 inhibitors Blood ·Shirley Mo, Alexander J. Ambinder, Amy E. DeZern, B. Douglas Smith, Ephraim J. Fuchs, Gabriel Ghiaur, Gabrielle T. Prince, Ivana Gojo, Javier Bolaños‐Meade, Jonathan Webster, Lukasz P. Gondek, Richard J. Jones, Tania Jain, Theodoros Karantanos, W. Brian Dalton, Mark J. Levis	2025	0
3	Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide Transplantation and Cellular Therapy ·Amy E. DeZern, Marianna Zahurak, Tyler Cavin, Helen Byrnes, Heather J. Symons, Kenneth R. Cooke, Carol Ann Huff, Tania Jain, Lode J. Swinnen, Philip Imus, Nina D. Wagner‐Johnston, Richard F. Ambinder, Ivana Gojo, Alexander J. Ambinder, Mark J. Levis, Cole Sterling, Javier Bolaños‐Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky	2025	0
4	Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors Journal of Clinical Oncology ·Brian C. Shaffer, Mahasweta Gooptu, Todd E. DeFor, Martin Maiers, Javier Bolaños‐Meade, Ramzi Abboud, Adrienne Briggs, Farhad Khimani, Dipenkumar Modi, Richard Newcomb, Elizabeth J. Shpall, Caitrin Bupp, Stephen R. Spellman, Heather E. Stefanski, Bronwen E. Shaw, Jeffery J. Auletta, Steven M. Devine, Antonio Jiménez, Monzr M. Al Malki	2024	20
5	Alternative donor BMT with post-transplant cyclophosphamide as initial therapy for acquired severe aplastic anemia Blood ·Amy E. DeZern, Marianna Zahurak, Heather J. Symons, Kenneth R. Cooke, Carol Ann Huff, Tania Jain, Lode J. Swinnen, Philip Imus, Nina D. Wagner‐Johnston, Richard F. Ambinder, Mark J. Levis, Leo Luznik, Javier Bolaños‐Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky	2023	18
6	Hyperinflammatory syndrome resembling haemophagocytic lymphohistiocytosis following axicabtagene ciloleucel and brexucabtagene autoleucel British Journal of Haematology ·Timothy J. Porter, Ana Lazarevic, Jamie E. Ziggas, Ephraim J. Fuchs, Kiryoung Kim, Helen Byrnes, Leo Luznik, Javier Bolaños‐Meade, Syed Abbas Ali, Nirali N. Shah, Nina D. Wagner‐Johnston, Tania Jain	2022	13
7	Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source Transplantation and Cellular Therapy ·Cole Sterling, Michael Sang Hughes, Hua‐Ling Tsai, Kathryn Yarkony, Ephraim J. Fuchs, Lode J. Swinnen, Suman Paul, Javier Bolaños‐Meade, Leo Luznik, Philip Imus, Syed Abbas Ali, Tania Jain, Alexander J. Ambinder, Amy E. DeZern, Carol Ann Huff, Christian B. Gocke, Ravi Varadhan, Nina D. Wagner‐Johnston, Richard J. Jones, Richard F. Ambinder	2022	6
8	Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study Journal of Clinical Oncology ·Ran Reshef, Wael Saber, Javier Bolaños‐Meade, George Chen, Yi‐Bin Chen, Vincent T. Ho, Doris M. Ponce, Ryotaro Nakamura, Michael J. Martens, John A. Hansen, John E. Levine	2021	15
9	Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide Transplantation and Cellular Therapy ·Katherine Rappazzo, Marianna Zahurak, Maria Bettinotti, Syed Abbas Ali, Alexander J. Ambinder, Javier Bolaños‐Meade, Ivan Borrello, Amy E. DeZern, Doug E Gladstone, Christian B. Gocke, Ephraim J. Fuchs, Carol Ann Huff, Philip Imus, Tania Jain, Leo Luznik, Leena Rahmat, Lode J. Swinnen, Nina D. Wagner‐Johnston, Richard J. Jones, Richard F. Ambinder	2021	10
10	Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide Biology of Blood and Marrow Transplantation ·Amy E. DeZern, Hany Elmariah, Marianna Zahurak, Gary L. Rosner, Douglas E. Gladstone, Syed Abbas Ali, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina D. Wagner‐Johnston, Richard F. Ambinder, Robert A. Brodsky, Kenneth R. Cooke, Leo Luznik, Ephraim J. Fuchs, Javier Bolaños‐Meade, Richard J. Jones	2020	22
11	Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia Biology of Blood and Marrow Transplantation ·Suman Paul, Hua-Ling Tsai, Patrick Lowery, Ephraim J. Fuchs, Leo Luznik, Javier Bolaños‐Meade, Lode J. Swinnen, Satish Shanbhag, Nina D. Wagner‐Johnston, Ravi Varadhan, Richard F. Ambinder, Richard J. Jones, Douglas E. Gladstone	2019	8
12	Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis Biology of Blood and Marrow Transplantation ·Mehdi Hamadani, Abraham S. Kanate, Alyssa DiGilio, Kwang Woo Ahn, Sonali M. Smith, Jong Wook Lee, Ernesto Ayala, Nelson J. Chao, Parameswaran Hari, Javier Bolaños‐Meade, Ronald E. Gress, Niels Smedegaard Anderson, Yi‐Bin Chen, Umar Farooq, Gary J. Schiller, Jean A. Yared, Anna Sureda, Timothy S. Fenske, Horatiu Olteanu	2017	22
13	Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma Biology of Blood and Marrow Transplantation ·Nilanjan Ghosh, Xiaobu Ye, Hua-Ling Tsai, Javier Bolaños‐Meade, Ephraim J. Fuchs, Leo Luznik, Lode J. Swinnen, Douglas E. Gladstone, Richard F. Ambinder, Ravi Varadhan, Satish Shanbhag, Robert A. Brodsky, Ivan Borrello, Richard J. Jones, William Matsui, Carol Ann Huff	2017	12
14	Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors Biology of Blood and Marrow Transplantation ·Jennifer A. Kanakry, Christopher D. Gocke, Javier Bolaños‐Meade, Douglas E. Gladstone, Lode J. Swinnen, Amanda L. Blackford, Ephraim J. Fuchs, Carol Ann Huff, Ivan Borrello, William Matsui, Robert A. Brodsky, Gary L. Rosner, Satish Shanbhag, Leo Luznik, Richard J. Jones, Richard F. Ambinder, Yvette L. Kasamon	2015	16
15	Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study Blood ·John E. Levine, Brent R. Logan, Juan Wu, Amin M. Alousi, Javier Bolaños‐Meade, James L.M. Ferrara, Vincent T. Ho, Daniel J. Weisdorf, Sophie Paczesny	2012	133
16	HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease Blood ·Javier Bolaños‐Meade, Ephraim J. Fuchs, Leo Luznik, Sophie Lanzkron, Christopher Gamper, Richard J. Jones, Robert A. Brodsky	2012	306
17	High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas Leukemia & lymphoma ·Douglas E. Gladstone, Javier Bolaños‐Meade, Carol Ann Huff, Marianna Zahurak, Ian W. Flinn, Ivan Borrello, Leo Luznik, Ephraim J. Fuchs, Yvette L. Kasamon, William Matsui, Jonathan D. Powell, Hyam I. Levitsky, Robert A. Brodsky, Richard F. Ambinder, Richard J. Jones, Lode J. Swinnen	2011	4
18	Correlation of clonogenic cancer stem cell (CSC) growth with clinical outcomes in multiple myeloma (MM) patients undergoing treatment with high dose cyclophosphamide (Cy) and rituximab Cancer Research ·Carol Ann Huff, Qiuju Wang, Kathryn Rogers, Miah Jung, Javier Bolaños‐Meade, Ivan Borrello, Richard J. Jones, William Matsui	2008	5
19	Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft‐versus‐host disease American Journal of Hematology ·Javier Bolaños‐Meade, Lan Zhou, Ahmet Höke, Andrea M. Corse, Georgia B. Vogelsang, Kathryn R. Wagner	2005	32
20	Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide Leukemia Research ·Javier Bolaños‐Meade, Judith E. Karp, Chuanfa Guo, C Sarkodee-Adoo, Aaron P. Rapoport, Michael L. Tidwell, Laxmi Narayana Buddharaju, T.Timothy Chen	2003	23

About Javier Bolaños‐Meade

Javier Bolaños‐Meade is a scholar working on Transplantation, Hematology, Genetics, Immunology and Oncology, having authored 119 papers that have together received 4.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (84 papers), Renal Transplantation Outcomes and Treatments (26 papers), Acute Lymphoblastic Leukemia research (22 papers), Immune Cell Function and Interaction (21 papers), Polyomavirus and related diseases (20 papers), Lymphoma Diagnosis and Treatment (15 papers), Acute Myeloid Leukemia Research (12 papers) and T-cell and B-cell Immunology (11 papers). The work is most often cited by research in Hematology (3.0k citations), Transplantation (413 citations), Genetics (892 citations), Immunology (1.4k citations) and Oncology (1.0k citations). Javier Bolaños‐Meade has collaborated with scholars based in United States, Mexico and France. Frequent co-authors include Richard J. Jones, Ephraim J. Fuchs, Robert A. Brodsky, Leo Luznik, Richard F. Ambinder, Vincent T. Ho, John E. Levine, Daniel J. Weisdorf, Carol Ann Huff and Marianna Zahurak. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Blood, Blood Advances, Journal of Clinical Oncology and Transplantation and Cellular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact